BRIEF published on 03/31/2026 at 13:12, 5 months 23 days ago Poxel Sells PXL770 to Scynexis for Up to $196 Million Biopharmaceutical Poxel PXL770 SCYNEXIS ADPKD
PRESS RELEASE published on 03/31/2026 at 13:07, 5 months 23 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Poxel announces sale of PXL770 for up to $196 million to SCYNEXIS. PXL770 targets ADPKD. Agreement includes upfront payment, development and commercial milestones. Phase 2 study planned for Q4 2026 Milestones Poxel PXL770 SCYNEXIS ADPKD
BRIEF published on 03/25/2026 at 22:03, 5 months 29 days ago Poxel Secures Additional Financing Through New Tranche D PDR Bonds Financing Continuation Plan Poxel IPF Partners Tranche D PDR
PRESS RELEASE published on 03/25/2026 at 21:58, 5 months 29 days ago Inside Information / News release on accounts, results Poxel confirms drawdown under Tranche D PDR bond issue for €3.75 million with IPF as part of continuation plan validated by Lyon Commercial Court. Key details and financing prospects outlined Financing Opportunities Poxel IPF Partners Tranche D PDR
BRIEF published on 02/03/2026 at 08:45, 7 months 20 days ago Poxel Establishes Equity Line with IRIS Capital Financing Recovery Plan Equity Line Poxel IRIS Capital
PRESS RELEASE published on 02/03/2026 at 08:40, 7 months 20 days ago Inside Information / Other news releases Poxel announces implementation of equity line with IRIS Capital as part of recovery plan. New financing structure to enhance financial foundation Financial Structure Recovery Plan Equity Line Poxel IRIS Capital
BRIEF published on 01/30/2026 at 08:02, 7 months 24 days ago Commercial Court of Lyon Approves Poxel's Recovery Plan Financial Strategy Recovery Plan Commercial Court Poxel Debts Settlement
PRESS RELEASE published on 01/30/2026 at 07:57, 7 months 24 days ago Inside Information / Other news releases Poxel SA receives approval for recovery plan from Commercial Court of Lyon, closing reorganisation proceedings and focusing on business development, cost optimization, settlement of liabilities, and financial strengthening Business Development Recovery Plan Financial Restructuring Poxel SA Commercial Court Of Lyon
BRIEF published on 12/11/2025 at 19:47, 9 months 12 days ago Results of the General Meeting of Poxel SA Shareholders Biopharmaceutical Company Recovery Plan Vote Results Poxel General Assembly
BRIEF published on 12/11/2025 at 19:47, 9 months 12 days ago Poxel Reports Outcomes of General Meeting and Looks Ahead Shareholders General Meeting Biopharmaceutical Recovery Plan Poxel
Published on 09/23/2026 at 22:00, 2 hours 3 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 5 hours 38 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 8 hours 21 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 9 hours 32 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 9 hours 33 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/23/2026 at 23:00, 1 hour 3 minutes ago Correction of a release from 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE WITH PREFERENTIAL SUBSCRIPTION RIGHTS AND THE PARTIAL EARLY REDEMPTION OF BONDS REDEEMABLE IN SHARES
Published on 09/23/2026 at 19:51, 4 hours 12 minutes ago LIGHTON: LightOn renews its bond financing with the same financial partners for a maximum nominal amount of €4 million, and thus extends its cash flow horizon
Published on 09/23/2026 at 18:05, 5 hours 58 minutes ago XPRIZE Wildfire Awards $4.55M to Innovators Advancing Wildfire Detection and Response
Published on 09/23/2026 at 18:00, 6 hours 3 minutes ago ARVERNE GROUP: Release of the 2026 half-year financial report
Published on 09/23/2026 at 18:00, 6 hours 3 minutes ago ARVERNE GROUP: First half of 2026 60.1% growth in gross business volume to €16.8 million Operational performance above expectations
Published on 09/23/2026 at 19:14, 4 hours 49 minutes ago Robust performance from Investments and continued execution of the strategy
Published on 09/23/2026 at 17:45, 6 hours 18 minutes ago Report on share repurchases from 16 to 21 September 2026
Published on 09/23/2026 at 17:45, 6 hours 18 minutes ago Infotel : H1 2026 RESULTS. Revenue growth of +9.4%.
